Slow opioid tapering compared to continued stable opioid therapy for chronic noncancer pain: A double-blinded randomized controlled trial
Journal of Opioid Management · 2026
DOI: 10.5055/jom.0969 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Opioid Management, 2026. Verfasst von Benjamin Lai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine, Mayo Clinic, Rochester, Minnesota. ORCID: https://orcid.org/0000-0002-6467-6179. Hauptthemen laut MEDLINE: Chronic Pain, Analgesics, Opioid, Drug Tapering, Tramadol. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objective
To investigate whether gradually discontinuing chronic opioid therapy (COT) affects quality of life (QOL), depression, and anxiety.
Design
Double-blinded, randomized controlled trial.
Setting
Ten primary care clinics in Wisconsin.
Participants
Adults on stable doses of COT for chronic noncancer pain.
Interventions
Participants were blinded and randomized to either a slow taper or to continue their COT. Participants were assessed at baseline, 3, 6, 9, and 12 months post-enrollment. Outcome measures: Primary outcomes were study completion and QOL, measured by the Medical Outcomes Study Questionnaire Short Form 36 Health Survey version 2. Secondary outcomes were depression and anxiety symptoms, measured using the Patient Health Questionnaire-9 Depression Scale and the Generalized Anxiety Disorder-7 Anxiety Scale, respectively.
Results
Of the 1,140 patients invited to participate, 18 enrolled—all prescribed tramadol or hydrocodone at the time of enrollment (median morphine milligram equivalents per day [MMED] of 17.5 mg; range: 5-40 MMED). Both groups had similar QOL and depression symptoms. The tapering group reported increased anxiety (p = 0.04).
Conclusion
Our findings suggest that opioids can be slowly tapered without affecting QOL or depression. Tapering led to a slight increase in anxiety. Larger-scale studies are needed to confirm our findings. Trial registration number: 21-009836 (ClinicalTrials.gov, Home|ClinicalTrials.gov). The trial was registered on March 22, 2022, “Slow Opioid Tapering Pilot Study of Patients Using Chronic Opioid Therapy.”
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Family Medicine, Mayo Clinic, Rochester, Minnesota. ORCID: https://orcid.org/0000-0002-6467-6179.
- Mayo Clinic Health System-Northwest Wisconsin, Eau Claire, Wisconsin. ORCID: https://orcid.org/0000-0002-2378-3621.
- University of Wisconsin-Eau Claire, Eau Claire, Wisconsin.
- Mayo Clinic Health System-Northwest Wisconsin, Eau Claire, Wisconsin.
- Beth Israel Deaconess Medical Center, Boston, Massachusetts. ORCID: https://orcid.org/0000-0002-2534-3363.
- Mayo Clinic, Rochester, Minnesota.
Zitieren
APA
Lai, B., Hidaka, B., Aziz, M., Schneider, T., Rich, J., Schmidt, R., Flock, C., Witt, D., Manley, M., & Witt, T. (2026). Slow opioid tapering compared to continued stable opioid therapy for chronic noncancer pain: A double-blinded randomized controlled trial. Journal of Opioid Management. https://doi.org/10.5055/jom.0969
Vancouver
Lai B, Hidaka B, Aziz M, Schneider T, Rich J, Schmidt R, et al. Slow opioid tapering compared to continued stable opioid therapy for chronic noncancer pain: A double-blinded randomized controlled trial. Journal of Opioid Management. 2026. doi:10.5055/jom.0969
BibTeX
@article{Lai2026,
author = {Lai, Benjamin and Hidaka, Brandon and Aziz, Mohammad and Schneider, Tasha and Rich, Jennifer and Schmidt, Rebecca and Flock, Carolyn and Witt, Daniel and Manley, Melissa and Witt, Terrence},
title = {Slow opioid tapering compared to continued stable opioid therapy for chronic noncancer pain: A double-blinded randomized controlled trial},
journal = {Journal of Opioid Management},
year = {2026},
doi = {10.5055/jom.0969}
}
EUVIMED